We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.825
Bid: 2.70
Ask: 2.95
Change: 0.025 (0.89%)
Spread: 0.25 (9.259%)
Open: 2.80
High: 2.825
Low: 2.80
Prev. Close: 2.80
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Brave Bison Group Plc

19 May 2017 15:33

RNS Number : 7187F
Huntress (CI) Nominees Limited
19 May 2017
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

HUNTRESS (CI) NOMINEES LIMITED

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Plum Tree Ltd

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Brave Bison Group Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18/05/2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

8,986,265

1.57

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

8,986,265

1.57

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

19 May 2017

Contact name:

Lee Hammond

Telephone number:

+44 (0)1481 732760

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETOKCDNQBKDBPD
Date   Source Headline
10th Apr 20247:00 amRNSNotice of Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSTrading Update
14th Dec 20234:15 pmRNSChange of Registered Office
12th Dec 20232:30 pmRNSGrant of RSU's and Director/PDMR Shareholding
23rd Nov 202311:00 amRNSDirector/PDMR Shareholding
20th Nov 20235:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSContract Wins & Investor Presentation
24th Oct 20235:15 pmRNSChange of Nominated Adviser and Broker
24th Oct 202312:30 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSHalf-year Report
4th Sep 20237:00 amRNSNotice of Results & Investor Presentation
29th Aug 202312:16 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
22nd Jun 20234:40 pmRNSHolding(s) in Company
14th Jun 20233:01 pmRNSResult of AGM
14th Jun 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSNotice of AGM
10th May 20238:18 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSFinal Results
19th Apr 20237:00 amRNSNotice of Results & Investor Presentation
10th Mar 20234:58 pmRNSHolding(s) in Company
9th Mar 202311:43 amRNSHolding(s) in Company
21st Feb 20231:34 pmRNSHolding(s) in Company
21st Feb 20231:33 pmRNSHolding(s) in Company
21st Feb 20231:32 pmRNSHolding(s) in Company
21st Feb 20231:30 pmRNSHolding(s) in Company
13th Feb 20235:50 pmRNSHolding(s) in Company
13th Feb 202310:23 amRNSHolding(s) in Company
7th Feb 20237:00 amRNSHolding(s) in Company
6th Feb 20235:28 pmRNSHolding(s) in Company
6th Feb 20235:04 pmRNSDirector/PDMR Shareholding
6th Feb 20231:06 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSAcquisition of Social Chain and Vendor Placing
14th Dec 20224:17 pmRNSHolding(s) in Company
7th Dec 202211:17 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSNew Financing Facility
22nd Sep 20227:00 amRNSHalf-year Report
16th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20223:17 pmRNSHolding(s) in Company
22nd Jul 20221:55 pmRNSHolding(s) in Company
21st Jul 20227:00 amRNSHalf Year Trading Update
11th Jul 20227:00 amRNSDirectorate Change
29th Jun 20225:04 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
6th Jun 20227:00 amRNSSignificant Contract Wins
27th May 20224:21 pmRNSNotice of AGM
29th Apr 20221:53 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.